PURPOSE: To evaluate the ability of magnetic resonance (MR) imaging en
hanced with AMI-25 to depict and characterize hepatic tumors. MATERIAL
S AND METHODS: Sixty-four patients (41 men and 23 women, aged 24-65 ye
ars [mean, 55 years]) underwent 1-T MR imaging: 22 had metastatic dise
ase; 10, hepatocellular carcinoma; seven, hemangioma; three, focal nod
ular hyperplasia; three, gallbladder adenocarcinoma; two, lymphoma; on
e, adenoma; and 16, no tumor. Pre- and postcontrast images (alone and
in combination) were analyzed by three independent radiologists. Recei
ver operating characteristic curves were constructed to compare tumor
characterization. RESULTS: Signal intensity was decreased in all benig
n tumors but not in malignant tumors. The number of tumors depicted (n
onenhanced images, 657 tumors; enhanced, 753; and combined, 760) was n
ot statistically different. Receiver operating characteristic curves d
id not show improved characterization with AMI-25.CONCLUSION: AMI-25 d
oes not improve depiction of hepatic tumors. Although characterization
of hepatic tumors was not improved with AMI-25, uptake of AMI-25 seem
s specific for hepatic tumors at MR imaging.